BSV portfolio can touch ₹5,000 cr in 3-4 yrs'
Business Standard|July 29, 2024
In one of the biggest pharmaceutical (pharma) deals in recent years, Delhi-based Mankind Pharma acquired Mumbai-headquartered specialty pharma company Bharat Serums and Vaccines (BSV) for ₹13,630 crore on Friday. RAJEEV JUNEJA, managing director (MD) and vice-chairman of Mankind Pharma, spoke to Sohini Das over the phone about the potential of the BSV portfolio to reach a ₹5,000 crore turnover in three to four years with Mankind's marketing prowess. Edited excerpts:
Sohini Das

Will this deal lead to Mankind Pharma focusing on exports too?

We have been very clear from the beginning that we don't want to get into exports with generic or me-too products. We always wanted products with a high level of entry barriers and complexity.

With the BSV deal, we now have branded products in some cases, there is no competition, and in others, there is limited competition (one or two players). For example, consider the AntiD product that BSV hasnearly 5-7 per cent of Indian mothers are Rh negative (blood group), which amounts to 8-10 million mothers.

Lack of preventive measures can cause brain damage or jaundice in & newborns. The mother needs to take a dose in the third trimester and within 72 hours after delivery with an Rh-positive child. Only 3040 per cent of expecting mothers adhere to this due to lack of awareness. BSV has the world's first and only recombinant for AntiRhoD, which has a valid patent until 2028. It also has vertically integrated in-house cell lines. If anyone tries to make any product of BSV, it would take five to 10 years at least. But we also feel there is huge potential for these products in the Indian market itself. Even after acquiring BSV, 87 per cent of the revenues of the entity will come from India. Wherever we have strong opportunities in the rest of the world, we will pursue them. Our ambition is to become a great company in India.

How do you wish to grow the synergies between BSV and Mankind?

Probably the fastest-growing therapy segment is infertility treatment. People are marrying late, then deciding to have a baby later on in their lives, focusing on careers, stress-myriad factors are affecting fertility.

هذه القصة مأخوذة من طبعة July 29, 2024 من Business Standard.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة July 29, 2024 من Business Standard.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من BUSINESS STANDARD مشاهدة الكل
Volumes, margins lead to earnings upgrade for Page Industries
Business Standard

Volumes, margins lead to earnings upgrade for Page Industries

Page Industries reported sales growth of 11 percent in Q2FY25 and volume growth of 7 percent year-on-year (Y-o-Y).

time-read
2 mins  |
November 09, 2024
With benchmarks becoming harder to beat, avoid very high-cost funds
Business Standard

With benchmarks becoming harder to beat, avoid very high-cost funds

The Securities and Exchange Board of India (Sebi) has, through a circular dated November 5, mandated that asset management companies must disclose expense ratios for direct and regular plans separately in their half-yearly statements.

time-read
2 mins  |
November 09, 2024
Sensex, Nifty fall for 2nd day on FPI selling
Business Standard

Sensex, Nifty fall for 2nd day on FPI selling

Stock markets closed lower for the second straight day on Friday amid relentless foreign fund outflows and losses in blue-chip stocks Reliance Industries, ICICI Bank, and State Bank of India.

time-read
1 min  |
November 09, 2024
Business Standard

NSE mulls launching new products to bolster commodities market

The National Stock Exchange (NSE) is seeking to expand its commodities segment by launching new products after examining the performance of energy, base metals, and bullion, an official of the domestic equity benchmark said on Friday.

time-read
1 min  |
November 09, 2024
Zinka Logistics sets price band for ₹1,115 cr IPO
Business Standard

Zinka Logistics sets price band for ₹1,115 cr IPO

Zinka Logistics Solutions Ltd, a digital platform for truck operators, on Friday said it has fixed a price band of ₹259-273 per share for its ₹1,115 crore initial share sale.

time-read
1 min  |
November 09, 2024
Swiggy IPO: QIBs do final-day heavylifting
Business Standard

Swiggy IPO: QIBs do final-day heavylifting

Issue subscribed 3.6x as institutional investors swoop in on Day 3 to corner 90% bids

time-read
2 mins  |
November 09, 2024
Business Standard

Adani Power cuts B'desh supply by more than 60%

Adani Power on Friday further reduced electricity supply to Bangladesh as the company seeks to recover more than $800 million in dues, according to data from Bangladesh's grid operator and two sources.

time-read
1 min  |
November 09, 2024
Beyond the syntax of national culture
Business Standard

Beyond the syntax of national culture

This book is not just a masterly exploration of India's linguistic civilisation. More importantly, it serves as a timely warning against recent attempts at conducting the epistemic study of Indian languages through a narrow prism of singularity.

time-read
4 mins  |
November 09, 2024
FORENSIC PROBE ALL SET TO BOOST CONVICTION RATE
Business Standard

FORENSIC PROBE ALL SET TO BOOST CONVICTION RATE

With Bharatiya Nyaya Sanhita making such investigation mandatory in serious crime cases that attract seven years' imprisonment or above, more and more criminals are likely to be brought to justice in the next five years

time-read
4 mins  |
November 09, 2024
'Ek hai toh safe hai': Modi in first rally for Maha polls
Business Standard

'Ek hai toh safe hai': Modi in first rally for Maha polls

Prime Minister Narendra Modi on Friday flagged the Congress' \"caste politics\" and cautioned the nation against it, while also accusing the grand old party of \"playing a dangerous game of pitting one caste against another\" for political gains.

time-read
2 mins  |
November 09, 2024